Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 17097375.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hypereosinophilic syndrome is a myeloproliferative disorder defined by unexplained, persistent hypereosinophilia with cutaneous or systemic involvement. We describe a patient with coexistence of hypereosinophilic syndrome and bullous pemphigoid. Treatment with the novel tyrosine kinase inhibitor imatinib mesylate resulted in durable remission of hypereosinophilia and skin lesions.
Medical subject headings
- Hypereosinophilic Syndrome
- Pemphigoid, Bullous
- Piperazines
- Protein Kinase Inhibitors
- Pyrimidines